Subthreshold diode micropulse laser versus observation in acute central serous chorioretinopathy

REFERENCES

• Spaide RF, Hall L, Haas A et al. Indocyanine green videoangiography of older patients with central serous chorioretinopathy. Retina Phila Pa 1996; 16: 203–213.
   PubMed Web of Science ®Google Scholar
• Gass JD. Pathogenesis of disciform detachment of the neuroepithelium. Am J Ophthalmol 1967; 63: 1–139.
   PubMed Web of Science ®Google Scholar
• Baran NV, Gürlü VP, Esgin H. Long‐term macular function in eyes with central serous chorioretinopathy. Clin Exp Ophthalmol 2005; 33: 369–372.
   PubMed Web of Science ®Google Scholar
• Cardillo piccolino F, Eandi CM, Ventre L et al. Photodynamic therapy for chronic central serous chorioretinopathy. Retina Phila Pa 2003; 23: 752–763.
   PubMed Web of Science ®Google Scholar
• Ma J, Meng N, Xu X et al. System review and meta‐analysis on photodynamic therapy in central serous chorioretinopathy. Acta Ophthalmol 2014; 92: e594–e601.
   Web of Science ®Google Scholar
• Robertson DM, Ilstrup D. Direct, indirect, and sham laser photocoagulation in the management of central serous chorioretinopathy. Am J Ophthalmol 1983; 95: 457–466.
   PubMed Web of Science ®Google Scholar
• Nicholson B, Noble J, Forooghian F et al. Central serous chorioretinopathy: update on pathophysiology and treatment. Surv Ophthalmol 2013; 58: 103–126.
   PubMed Web of Science ®Google Scholar
• Chen S‐N, Hwang J‐F, Tseng L‐F et al. Subthreshold diode micropulse photocoagulation for the treatment of chronic central serous chorioretinopathy with juxtafoveal leakage. Ophthalmology 2008; 115: 2229–2234.
   PubMed Web of Science ®Google Scholar
• Koss MJ, Beger I, Koch FH. Subthreshold diode laser micropulse photocoagulation versus intravitreal injections of bevacizumab in the treatment of central serous chorioretinopathy. Eye Lond Engl 2012; 26: 307–314.
   PubMed Web of Science ®Google Scholar
• Behnia M, Khabazkhoob M, Aliakbari S et al. Improvement in visual acuity and contrast sensitivity in patients with central serous chorioretinopathy after macular subthreshold laser therapy. Retina Phila Pa 2013; 33: 324–328.
   PubMed Web of Science ®Google Scholar
• Hata M, Oishi A, Shimozono M et al. Early changes in foveal thickness in eyes with central serous chorioretinopathy. Retina Phila Pa 2013; 33: 296–301.
   Web of Science ®Google Scholar
• Gawecki M, Jaszczuk‐maciejewska A, Jurska‐jasko A et al. Functional and morphological outcome in patients with chronic central serous chorioretinopathy treated by subthreshold micropulse laser. Graefes Arch Clin Exp Ophthalmol 2017; 255: 2299–2306.
   PubMed Web of Science ®Google Scholar
• Arora S, Pyare R, Sridharan P et al. Choroidal thickness evaluation of healthy eyes, central serous chorioretinopathy, and fellow eyes using spectral domain optical coherence tomography in Indian population. Indian J Ophthalmol 2016; 64: 747–751.
   Web of Science ®Google Scholar
• Brancato R, Pece A, Avanza P et al. Photocoagulation scar expansion after laser therapy for choroidal neovascularization in degenerative myopia. Retina Phila Pa 1990; 10: 239–243.
   PubMed Web of Science ®Google Scholar
• Schatz H, Yannuzzi LA, Gitter KA. Subretinal neovascularization following argon laser photocoagulation treatment for central serous chorioretinopathy: complication or misdiagnosis? 1975. Retina Phila Pa. 2012; 32: OP893–OP906.
   Google Scholar
• Schlötzer‐schrehardt U, Viestenz A, Naumann GO et al. Dose‐related structural effects of photodynamic therapy on choroidal and retinal structures of human eyes. Graefes Arch Clin Exp Ophthalmol 2002; 240: 748–757.
   PubMed Web of Science ®Google Scholar
• Lai TYY, Chan W‐M, Lam DSC. Transient reduction in retinal function revealed by multifocal electroretinogram after photodynamic therapy. Am J Ophthalmol 2004; 137: 826–833.
   Web of Science ®Google Scholar
• Tzekov R, Lin T, Zhang K‐M et al. Ocular changes after photodynamic therapy. Invest Ophthalmol Vis Sci 2006; 47: 377–385.
   PubMed Web of Science ®Google Scholar
• Sivaprasad S, Elagouz M, Mchugh D et al. Micropulsed diode laser therapy: evolution and clinical applications. Surv Ophthalmol 2010; 55: 516–530.
   PubMed Web of Science ®Google Scholar
• Luttrull JK. Low intensity/high density subthreshold diode micropulse laser for central serous chorioretinopathy. Retina Phila Pa. 2016; 36: 1658–1663.
   PubMed Web of Science ®Google Scholar
• Malik KJ, Sampat KM, Mansouri A et al. Low‐intensity/ high density subthreshold micropulse diode laser for chronic central serous chorioretinopathy. Retina 2015; 35: 532–536.
   PubMed Web of Science ®Google Scholar
• Roisman L, Magalhães FP, Lavinsky D et al. Micropulse diode laser treatment for chronic central serous chorioretinopathy: a randomized pilot trial. Ophthalmic Surg Lasers Imaging Retina 2013; 44: 465–470.
   PubMed Web of Science ®Google Scholar
• Kretz FT, Beger I, Koch F et al. Randomized clinical trial to compare micropulse photocoagulation versus half‐dose verteporfin photodynamic therapy in the treatment of central serous chorioretinopathy. Ophthalmic Surg Lasers Imaging Retina 2015; 46: 837–843.
   Web of Science ®Google Scholar
• Yadav NK, Jayadev C, Mohan A et al. Subthreshold micropulse yellow laser (577 nm) in chronic central serous chorioretinopathy: safety profile and treatment outcome. Eye (Lond) 2015; 29: 258–264.
   PubMed Web of Science ®Google Scholar
• Lanzetta P, Furlan F, Morgante L et al. Nonvisible subthreshold micropulse diode laser (810 nm) treatment of central serous chorioretinopathy. A pilot study. Eur J Ophthalmol 2008; 18: 934–940.
   PubMed Web of Science ®Google Scholar
• Ricci F, Missiroli F, Regine F et al. Indocyanine green enhanced subthreshold diode‐laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy. Graefes Arch Clin Exp Ophthalmol 2009; 247: 597–607.
   PubMed Web of Science ®Google Scholar
• Gupta B, Elagouz M, Mchugh D et al. Micropulse diode laser photocoagulation for central serous chorio‐retinopathy. Clin Exp Ophthalmol 2009; 37: 801–805.
   Web of Science ®Google Scholar
• Breukink MB, Mohr JK, Ossewaarde van norel A et al. Half dose photodynamic therapy followed by diode micropulse laser therapy as treatment for chronic central serous chorioretinopathy: evaluation of a prospective treatment protocol. Acta Ophthalmol 2016; 94: 187–197.
   Web of Science ®Google Scholar
• Scholz P, Ersoy L, Boon CJF et al. Subthreshold micropulse laser (577 nm) treatment in chronic central serous chorioretinopathy. Ophthalmologica 2015; 234: 189–194.
   PubMed Web of Science ®Google Scholar
• Gawęcki M. Increase in central retinal edema after subthreshold diode micropulse laser treatment of chronic central serous chorioretinopathy. Case Rep Ophthalmol Med 2015; 2015: 813414.
   Web of Science ®Google Scholar
• Luttrull JK, Sramek C, Palanker D et al. Long‐term safety, high‐resolution imaging, and tissue temperature modeling of subvisible diode micropulse photocoagulation for retinovascular macular edema. Retina Phila Pa 2012; 32: 375–386.
   PubMed Web of Science ®Google Scholar
• Luttrull JK, Sinclair SH. Safety of transfoveal subthreshold diode micropulse laser for fovea‐involving diabetic macular edema in eyes with good visual acuity. Retina Phila Pa 2014; 34: 2010–2020.
   Web of Science ®Google Scholar
• Luttrull JK, Dorin G. Subthreshold diode micropulse laser photocoagulation (SDM) as invisible retinal phototherapy for diabetic macular edema: a review. Curr Diabetes Rev 2012; 8: 274–284.
   PubMedGoogle Scholar
• Giovannini A, Scassellati‐sforzolini B, D'altobrando E et al. Choroidal findings in the course of idiopathic serous pigment epithelium detachment detected by indocyanine green videoangiography. Retina Phila Pa 1997; 17: 286–293.
   PubMed Web of Science ®Google Scholar
• Wong KH, Lau KP, Chhablani J et al. Central serous chorioretinopathy: what we have learnt so far. Acta Ophthalmol 2016; 94: 321–325.
   PubMed Web of Science ®Google Scholar
• Maruko I, Iida T, Sugano Y et al. Subfoveal choroidal thickness in fellow eyes of patients with central serous chorioretinopathy. Retina Phila Pa 2011; 31: 1603–1608.
   PubMed Web of Science ®Google Scholar
• Luttrull JK, Margolis BWL. Functionally guided retinal protective therapy for age‐related macular and inherited retinal degenerations. A pilot study. Invest Ophthalmol Vis Sci 2016; 57: 265–275.
   PubMed Web of Science ®Google Scholar
• Luttrull JK, Chang DB, Margolis BWL et al. Laser resensitization of medically unresponsive neovascular age‐related macular degeneration: efficacy and implications. Retina 2015; 35: 1184–1194.
   PubMed Web of Science ®Google Scholar
• Luttrull JK, Musch MC, Mainster MA. Subthreshold diode micropulse photocoagulation for the treatment of clinically significant diabetic macular edema. Br J Ophthalmol 2005; 89: 74–80.
   PubMed Web of Science ®Google Scholar